logo-loader
TSX-V:BCT OTCQB:BCTXF FRA:8BT

Briacell Therapeutics Corp.

Market:
TSX-V
Market Cap:
$4.63 m
Price
6.00 CAD
Change
-0.83%
52 weeks high
27.00
52 weeks low
0.04

In brief

BriaCell is a clinical stage immuno-oncology focused biotechnology company developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.